The high risk of contamination, costs associated to open system isolators and a shortage of technicians may hamper the growth of the market during the assessment period.
The pharmaceutical industry is known as highly regulated industry and it is necessary to maintain the aseptic environment during the manufacturing process to meet the standards. Pharmaceutical isolators provide aseptic conditions and prevent the operator from being exposed to hazardous elements. The growing adoption of new technology in the manufacturing process, increasing use of open system isolators in research and development activities, and stringent regulatory policies are the major factors driving the growth of the global open system isolator market.
Additionally, increasing R&D spending and aggressive strategies adopted by the top players, such as new product launches, are contributing to the growth of the market. For instance, in March 2017, COMECER S.p.A. cf. p.iva . has introduced The New Thecla Shielded Isolator in the market, this new isolator was introduced in the global market which will be available for use in academic as well as commercial manufacturing.
The market in the Americas is expected to dominate the global open system isolator market during the forecast period owing to the increasing pharmaceutical manufacturing, strict government and regulatory authorities and well-established healthcare sector in the region. The European market is expected to be the second-largest due to the surge in research and development activities in the region along with growing concern about safety and efficacy of pharmaceutical products. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to increasing production of generic pharmaceuticals in the region along with an increase in a number of manufacturing plants due to favorable conditions. The market in the Middle East & Africa is likely to account for the smallest share of the global open system isolator market.
Asia-Pacific is expected to be the fastest-growing open system isolator market during the forecast period owing to the presence of a strong generics market and increasing export of generic drugs from the countries like China and India. For instance, according to the Indian Brand Equity Foundation (Ministry of Commerce & Industry, Government of India), Indian companies exported pharmaceuticals worth USD 17.27 billion during 2017 to 2018 which is expected to grow at a rate of 30% to reach USD 20 billion by 2020.
The global open system isolator market has been segmented on the basis of pressure, application, and end-user.
The market by pressure has been divided into positive pressure isolators and negative pressure isolators.
On the basis of application, the market has been divided into, fluid dispensing isolators, aseptic filling isolators, product contaminants isolators, sampling/weighing/distribution isolators, and others
The end-user segment has been classified into pharmaceutical and biotechnological industries, academic & research institutes, hospitals and diagnostic laboratories and others.
Some of the key players in the global open system isolator market are Schematic Engineering Industries, Gelman Singapore Pte Ltd, COMECER S.p.A. cf. p.iva, Getinge AB, IsoTech Design, LAF Technologies Pty Ltd, Fedegari Autoclavi S.p.A, Hosokawa Micron Ltd, Robert Bosch GmbH, Azbil Telstar, MBRAUN, NuAire Inc, VanRx Pharmasystems Inc, Skan AG, Chamunda Pharma Machinery Pvt. Ltd., and GERMFREE